<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        0102244823
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2024
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        Aquipta
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        Atogepant
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        10
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        28
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        1343.05
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Forest Laboratories Ireland Limited" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Forest Laboratories Ireland Limited
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 359]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Cigalah Group
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Abbvie Limited
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        N02C-ANTIMIGRAINE PREPARATIONS
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>AQUIPTA contains the active substance atogepant.</p><p><strong>How AQUIPTA works</strong></p><p>AQUIPTA works by blocking the activity of the calcitonin gene-related peptide (CGRP) molecule which has been linked to migraine. This reduction in CGRP&rsquo;s activity reduces migraine attacks.</p><p><strong>What AQUIPTA is used for</strong></p><p>AQUIPTA is used to prevent migraine in adult patients who have at least 4 migraine days per</p><p>month.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not use AQUIPTA:</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you are allergic to atogepant or any of the other ingredients of this medicine (listed in section&nbsp;6).</p><p><strong>Warnings and precautions</strong></p><p>Talk to your doctor, pharmacist or nurse before taking AQUIPTA, especially if you:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; have liver problems</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; have kidney problems</p><p>&nbsp;</p><p>Allergic reactions</p><p>Stop taking AQUIPTA and tell your doctor immediately if you experience any symptoms of an allergic reaction such as:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; difficulty breathing</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; swelling of the face</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; rash, itching, or hives</p><p>&nbsp;</p><p>Some of these symptoms can occur several days after you take AQUIPTA.</p><p><s>&nbsp;</s></p><p><strong>Children and adolescents</strong></p><p>Do not give this medicine to children or adolescents (under 18 years old) because the use of</p><p>AQUIPTA has not been studied in this age group.</p><p>1</p><p>&nbsp;</p><p><strong>Other medicines and AQUIPTA </strong></p><p>Tell your doctor or pharmacist if you are taking, have recently taken or might take any other</p><p>medicines. Some medicines may increase the risk of getting side effects.</p><p>The following is a list of examples of&nbsp; medicines that may require , your doctor <s>may need</s> to lower the dose of AQUIPTA:</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ketoconazole, itraconazole, voriconazole, clarithromycin, telithromycin, rifampicin (medicines used to treat fungal or bacterial infections)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; atazanavir, indinavir, nelfinavir, ritonavir, saquinavir, tipranavir (medicines used to treat HIV)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ciclosporin (medicine that affects your immune system)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; telmisartan (medicine used to treat high blood pressure)</p><p>&nbsp;</p><p>If any of the above apply to you or you are not sure, talk to your doctor or pharmacist before taking AQUIPTA.</p><p><strong>Pregnancy, breast-feeding and fertility</strong></p><p>AQUIPTA is not recommended during pregnancy.</p><p>If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before using this medicine.</p><p><strong>Driving and using machines</strong></p><p>AQUIPTA may make you feel sleepy. Do not drive or use machines if you are affected.</p><p>&nbsp;</p><p><strong>AQUIPTA contains sodium</strong></p><p>This medicine contains 31.5 mg sodium (main component of cooking/table salt) in each 60 mg tablet. This is equivalent to 1.6% of the recommended maximum daily dietary intake of sodium for an adult.</p><p>&nbsp;</p><p>This medicine contains less than 1 mmol sodium (23 mg) per 10 mg tablet, that is to say essentially &lsquo;sodium-free&rsquo;.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Always take this medicine exactly as your doctor has told you. </strong>Speak to your doctor or pharmacist if you are not sure.</p><p><strong>How much to take</strong></p><p>The recommended dose is 60 mg once a day. Your doctor may tell you to take a lower dose if you are taking other medicines (listed in section 2) or if you have severe kidney problems. Speak to your doctor if you are undergoing dialysis.</p><p><strong>How to take</strong></p><p>AQUIPTA may be taken with or without food.</p><p><strong>If you take more AQUIPTA than you should</strong></p><p>If you have used more AQUIPTA than you should, tell your doctor.</p><p><strong>If you forget to take AQUIPTA </strong></p><p>A missed dose should be taken straight away. If it is close to your scheduled next dose, do not take a</p><p>double dose to make up for a forgotten tablet.</p><p><strong>If you stop taking AQUIPTA </strong></p><p>Do not stop using AQUIPTA without talking to your doctor first. Your symptoms may return if</p><p>you stop the treatment.</p><p>If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.</p><p><strong>&nbsp;</strong></p><p><strong>Serious side effects</strong></p><p>Stop taking AQUIPTA and contact your doctor immediately if you have any of the following symptoms, which may be part of a serious allergic reaction:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; difficulty breathing</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; swelling of the face</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; rash, itching, or hives</p><p><strong><u>Other side effects</u></strong></p><p>Tell your doctor or nurse if you notice any of the following side effects:</p><p><strong>Common </strong>(may affect up to 1 in 10 people):</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling sick (nausea)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; constipation</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; tiredness (fatigue) or sleepiness (somnolence)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; decreased appetite</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; weight loss</p><p><strong>Uncommon </strong>(may affect up to 1 in 100 people):</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; increased levels of liver enzymes</p><p><s>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </s><s>&nbsp;</s></p><p><strong>&nbsp;</strong></p><p><u>Reporting side effects&nbsp;&nbsp; </u></p><p>If any of the side effects get serious, or if you notice any side effects not mentioned in this leaflet, please tell your doctor or pharmacist. You can also report side effects directly via national reporting system listed in section 6.&nbsp; By reporting side effects you can help provide more information on the safety of the medicine.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep this medicine out of the sight and reach of children.</p><p>This medicinal product does not require any special storage conditions.</p><p>Do not use this medicine after the expiry date which is stated on the carton and blister after EXP. The expiry date refers to the last day of that month.</p><p>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>What AQUIPTA contains </strong><br />The active substance is atogepant.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Each tablet contains either 10 mg or 60 mg of atogepant.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The other ingredients are: Polyvinylpyrrolidone/Vinyl acetate copolymer, vitamin E polyethylene glycol succinate, mannitol, microcrystalline cellulose, sodium chloride, croscarmellose sodium, colloidal silicon dioxide and sodium stearyl fumarate.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                AQUIPTA  10 mg tablets 
AQUIPTA  10 mg tablet is a white to off-white, round biconvex tablet debossed with “A” and
“10” on one side.
AQUIPTA  60 mg tablets 
AQUIPTA  60 mg tablet is a white to off-white, oval biconvex tablet debossed with “A60” on one
side.
Each blister contains 7 tablets, each pack contains 28 tablets.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Manufacturer</strong></p><p>Forest Laboratories Ireland, Limited</p><p>Clonshaugh Business and Technology Park</p><p>Clonshaugh, Dublin 17, Ireland</p><p>&nbsp;</p><p><strong>&nbsp;</strong></p><p><strong>Marketing Authorization Holder</strong></p><p>AbbVie Ltd.</p><p>Maidenhead</p><p>SL6 4UB</p><p>UK</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was revised in 07/2024.
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">يحتوي أكويبتا على المادة الفعالة اتوجيبانت.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>كيف يعمل </strong><strong>أكويبتا</strong></p><p dir="RTL">يعمل أكويبتا عن طريق منع نشاط جزيء الببتيد المرتبط بجين الكالسيتونين (CGRP) المرتبط بالصداع النصفي. هذا الانخفاض في نشاط الببتيد المرتبط بجين الكالسيتونين يقلل من نوبات الصداع النصفي.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>استخدامات </strong><strong>أكويبتا</strong></p><p dir="RTL">يستخدم أكويبتا لمنع الصداع النصفي لدى المرضى البالغين الذين يعانون من الصداع النصفي لمدة 4 أيام على الأقل في الشهر.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>&nbsp;</strong></p><p><strong>لا تستخدم أكويبتا</strong><strong>:</strong></p><p><strong>&nbsp;</strong></p><p dir="RTL">&nbsp;إذا كان لديك حساسية من اتوجيبانت أو أي من المكونات الأخرى لهذا الدواء (المدرجة في القسم ٦)</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>المحاذير والاحتياطات</strong></p><p dir="RTL"><s>&nbsp;</s></p><p dir="RTL">تحدث إلى طبيبك أو الصيدلاني أو الممرضة قبل تناول أكويبتا ، وخاصة إذا كنت:</p><p dir="RTL">&bull; تعاني من مشاكل في الكبد</p><p dir="RTL">&bull; تعاني من مشاكل في الكلى</p><p dir="RTL">&nbsp;</p><p dir="RTL">ردود الفعل التحسسية</p><p dir="RTL">توقف عن تناول أكويبتا وأخبر طبيبك على الفور إذا واجهت أي أعراض لرد فعل تحسسي مثل:</p><p dir="RTL">&bull; صعوبة في التنفس</p><p dir="RTL">&bull; تورم في الوجه</p><p dir="RTL">&bull; طفح جلدي أو حكة أو شرى</p><p dir="RTL">&nbsp;</p><p dir="RTL">يمكن أن تحدث بعض هذه الأعراض بعد عدة أيام من تناول أكويبتا.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الأطفال والمراهقون</strong></p><p dir="RTL">لا تعط هذا الدواء للأطفال أو المراهقين (أقل من 18 سنة) لأن أكويبتا لم تتم دراسته على هذه الفئة العمرية.</p><p>&nbsp;</p><p dir="RTL"><strong>الأدوية الأخرى وأكويبتا</strong></p><p dir="RTL">أخبر طبيبك أو الصيدلي إذا كنت تتناول أو تناولت مؤخرًا أو قد تأخذ أي دواء آخر. قد تزيد بعض الأدوية من خطر حدوث آثار جانبية.</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا كنت تتناول أيًا من الأدوية التالية، فقد يحتاج طبيبك إلى تقليل جرعة أكويبتا :</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;&bull;كيتوكونازول، إيتراكونازول، فوريكونازول، كلاريثروميسين، تيليثروميسين، ريفامبيسين (أدوية تستخدم لعلاج الالتهابات الفطرية أو البكتيرية).</p><p dir="RTL">&nbsp;&bull; أتازانافير، إندينافير، نلفينافير، ريتونافير، ساكوينافير، تيبرانافير (أدوية تستخدم لعلاج فيروس نقص المناعة البشرية).</p><p dir="RTL">&bull; سيكلوسبورين (دواء يؤثر على جهاز المناعة).</p><p dir="RTL">&bull; تلميسارتان (دواء يستخدم لعلاج ارتفاع ضغط الدم).</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا كان أي مما سبق ينطبق عليك أو لم تكن متأكدًا، فتحدث إلى طبيبك أو الصيدلي قبل تناول أكويبتا.</p><p>&nbsp;</p><p dir="RTL"><strong>الحمل والرضاعة والخصوبة</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">لا ينصح باستخدام أكويبتا أثناء الحمل.</p><p dir="RTL">إذا كنت حاملًا أو مرضعة، أو تعتقدين أنك حامل أو تخططين لإنجاب طفل، اسألي طبيبك للحصول على المشورة قبل استخدام هذا الدواء.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>القيادة واستعمال الآلات</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">قد يجعلك أكويبتا تشعر بالنعاس. لا تقود السيارة أو تستخدم الآلات إذا كنت متأثرًا.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>يحتوي</strong><strong> </strong><strong>أكويبتا</strong><strong> </strong><strong>على الصوديوم</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">يحتوي هذا الدواء على 31.5 ملجم صوديوم (المكون الرئيسي لملح الطعام/الملح المستخدم في الطهي) في كل قرص 60 ملجم. وهذا يعادل 1.6% من الحد الأقصى الموصى به من الصوديوم في النظام الغذائي اليومي للبالغين.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يحتوي هذا الدواء على أقل من 1 مليمول صوديوم (23 ملجم) لكل قرص 10 ملجم، أي أنه &quot;خالي من الصوديوم&quot; بشكل أساسي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>احرص دائمًا على اتباع تعليمات طبيبك عند تناول هذا الدواء. </strong>تحدث إلى طبيبك أو الصيدلي إذا لم تكن متأكدًا من كيفية تناوله.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الكمية الموصى بها</strong></p><p dir="RTL">الجرعة الموصي بها هي 60 مجم مرة يوميًا. قد يخبرك طبيبك بتناول جرعة أقل إذا كنت تتناول أدوية أخرى (مدرجة في القسم 2) أو إذا كنت تعاني من مشاكل حادة في الكلى. تحدث إلى طبيبك إذا كنت تخضع لغسيل الكلى.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>كيفية تناول أقراص أكويبتا</strong></p><p dir="RTL">يمكن تناول أكويبتا مع الطعام أو بدونه.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>في حال تناول جرعة أكبر مما ينبغي </strong><strong>من أكويبتا</strong></p><p dir="RTL">يجب أن تخبر طبيبك في حال تناولت جرعة أكبر مما ينبغي من أكويبتا</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>في حال نسيان تناول أكويبتا </strong></p><p dir="RTL">يجب تناول الجرعة الفائتة على الفور، ومع ذلك إذا كان الوقت قد حان للجرعة المجدولة التالية ، فتجاوز الجرعة الفائتة واستمر في جدول الجرعات المعتاد ، لا تأخذ جرعة مضاعفة لتعويض ما فاتك.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>في حال التوقف عن تناول أكويبتا</strong></p><p dir="RTL">لا تتوقف عن استخدام أكويبتا دون التحدث إلى طبيبك أولاً. قد تعود الأعراض الخاصة بك إذا توقفت عن تناول العلاج.</p><p dir="RTL">إذا كان لديك أي أسئلة أخرى حول استخدام هذا الدواء، اسأل طبيبك أو الصيدلي أو الممرضة.</p><p><br />&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">إن هذا الدواء مثل جميع الأدوية قد يسبب آثارًا جانبية، على الرغم من عدم ظهورها على الجميع.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong><u>الآثار الجانبية الخطيرة</u></strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">توقف عن تناول أكويبتا&nbsp; واتصل بطبيبك على الفور إذا ظهرت عليك أي من الأعراض التالية، والتي قد تكون جزءًا من رد فعل تحسسي خطير:</p><p dir="RTL">&nbsp;&bull; صعوبة في التنفس</p><p dir="RTL">&bull; &nbsp;تورم الوجه</p><p dir="RTL">&nbsp;&bull; طفح جلدي أو حكة أو شرى</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong><u>آثار جانبية أخرى</u></strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا ظهرت لديك أي من هذه الآثار الجانبية، فاستشر طبيبك أو الممرض.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>من الآثار الجانبية الشائعة</strong>: قد تظهر لدى أكثر من 1 من كل 10 أشخاص</p><p dir="RTL">&nbsp;</p><p dir="RTL">&middot;&nbsp;&nbsp; الشعور بالغثيان.</p><p dir="RTL">&middot;&nbsp;&nbsp; الإمساك</p><p dir="RTL">&middot;&nbsp;&nbsp; التعب (الإرهاق) أو النعاس.</p><p dir="RTL">&middot;&nbsp;&nbsp; فقدان الشهية</p><p dir="RTL">&middot;&nbsp;&nbsp; فقدان الوزن</p><p dir="RTL">&nbsp;</p><p><strong>غير</strong> <strong>شائعة</strong> (قد تظهر لدى حتى 1 من كل 100 شخص)</p><p>زيادة مستويات إنزيمات الكبد</p><p>&nbsp;</p><p dir="RTL"><s>&nbsp;</s></p><p dir="RTL"><u>الإبلاغ عن الآثار الجانبية</u></p><p dir="RTL">إذا تفاقمت أي من الآثار الجانبية، أو إذا لاحظت أي آثار جانبية غير مذكورة في هذه النشرة، فيرجى استشارة طبيبك أو الصيدلي. يمكنك أيضًا الإبلاغ عن الآثار الجانبية مباشرةً من خلال نظام الإبلاغ الوطني المُدرج في القسم 6. من خلال الإبلاغ عن الآثار الجانبية، يمكن أن تساعد في توفير مزيد من المعلومات حول أمان هذا الدواء.</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">احفظ الدواء بعيدًا عن متناول الأطفال وأنظارهم.</p><p dir="RTL">لا يتطلب هذا المنتج الطبي أي شروط تخزين خاصة.</p><p dir="RTL">&nbsp;</p><p dir="RTL">لا تستخدم هذا الدواء بعد تاريخ انتهاء الصلاحية المدون على العلبة وشريط المستحضر بعد تاريخ انتهاء الصلاحية. يشير تاريخ انتهاء الصلاحية إلى اليوم الأخير من نفس الشهر.</p><p dir="RTL">&nbsp;</p><p dir="RTL">لا&nbsp;ينبغي&nbsp;التخلص&nbsp;من&nbsp;الأدوية عن&nbsp;طريق&nbsp;مياه الصرف الصحي&nbsp;أو&nbsp;النفايات المنزلية.&nbsp;اسأل الصيدلي عن كيفية التخلص&nbsp;من&nbsp;الأدوية التي لم تعد تستخدمها. ومن شأن هذه التدابير أن تساعد على حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>ما هي محتويات </strong><strong>أكويبتا</strong></p><p dir="RTL">المادة الفعّالة هي اتوجيبانت.</p><p dir="RTL">- يحتوي كل قرص إما على 10 مجم أو 60 مجم من اتوجيبانت.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المكونات الأخرى هي: بولي فينيل بيروليدون / فينيل أسيتات كوبوليمر، فيتامين هـ &nbsp;بولي إيثيلين جليكول سكسينات، مانيتول، سليلوز دقيق التبلور، كلوريد الصوديوم، كروس كارميلوز الصوديوم، ثاني أكسيد السيليكون الغرواني، فومارات ستيريل الصوديوم.</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">أقراص <u>أكويبتا 10 مجم</u></p><p dir="RTL">قرص أكويبتا 10 مجم هو قرص لونه ما بين الأبيض والأبيض المائل للصفرة، بيضاوي محدب الوجهين منقوش عليه الحرف &quot;A&quot; و&quot;10&quot; على أحد الجانبين.</p><p dir="RTL">&nbsp;</p><p dir="RTL">أقراص <u>أكويبتا 60 مجم</u></p><p dir="RTL">قرص أكويبتا 60 مجم هو قرص لونه ما بين الأبيض والأبيض المائل للصفرة، بيضاوي محدب الوجهين منقوش عليه الحرف &quot;A60&quot; على أحد الجانبين.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يحتوي كل شريط على 7 أقراص، وتحتوي كل عبوة على 28 قرص</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>الشركة المصنعة</strong></p><p>شركة فورست لابوراتوريز أيرلاندا، ليمتد</p><p dir="RTL">دبلن ، أيرلندا&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>الشركة المسوقة</strong><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong></p><p><strong>&nbsp;</strong>آبفي ليمتد</p><p>ميدنهيد، إس إل ٦ ٤ يو بي<strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong></p><p>المملكة المتحدة<strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong></p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تمت مراجعة هذه النشرة في 07/2024.
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                AQUIPTA 10 mg tablets
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                AQUIPTA 10 mg tablets
Each tablet contains 10 mg of atogepant
For the full list of excipients, see section 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                AQUIPTA 10 mg tablets 
White to off-white, round biconvex tablet debossed with “A” and “10” on one side.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>AQUIPTA is indicated for prophylaxis of migraine in adults who have at least 4 migraine days per month.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Posology </u>&nbsp;</p><p>The recommended dose for AQUIPTA is 60 mg taken orally once daily with or without food. A missed dose should be taken right away. If it is almost time for the next dose, patients should be instructed to skip the missed dose and take the next dose as scheduled.</p><p><em>Dose modifications</em></p><p>Dosing modifications for concomitant use of specific drugs are provided in Table 1 (see section 4.5).</p><p><strong>Table 1: Dose modifications for drug interactions</strong></p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>Dosage modifications</strong></p></td><td style="vertical-align:top"><p><strong>Recommended<br />once daily dose</strong></p></td></tr><tr><td style="vertical-align:top"><p>Strong CYP3A4 inhibitors</p></td><td style="vertical-align:top"><p>10 mg</p></td></tr><tr><td style="vertical-align:top"><p>Strong OATP inhibitors</p></td><td style="vertical-align:top"><p>10 mg</p></td></tr></tbody></table><p>&nbsp;</p><p><em>Special populations</em></p><p>1</p><p>&nbsp;</p><p><em><u>Elderly (&gt;65 years) </u></em></p><p>There is limited data available in the elderly with no data available in patients over 80 years of age. Population pharmacokinetic modelling suggests no clinically significant pharmacokinetic differences between elderly and younger subjects. No dose adjustment of AQUIPTA is needed in elderly patients.</p><p><em><u>Hepatic impairment</u></em></p><p>Avoid use of AQUIPTA in patients with severe hepatic impairment. No dose adjustment is recommended for patients with mild or moderate hepatic impairment (see section 5.2).</p><p><em><u>Renal impairment</u></em></p><p>In patients with severe renal impairment (CLcr 15-29 mL/min), and in patients with end-stage renal disease (ESRD) (CLcr &lt;15 mL/min), the recommended dosage of AQUIPTA is 10 mg once daily. For patients with ESRD undergoing intermittent dialysis, AQUIPTA should preferably be taken after dialysis. No dose</p><p>adjustment is recommended for patients with mild or moderate renal impairment (see section 5.2).</p><p><em><u>Paediatric population </u></em></p><p>The safety and efficacy of atogepant in children have not yet been established. No data are available.</p><p><u>Method of administration </u></p><p>AQUIPTA is to be taken orally once daily with or without food.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to the active substance or to any of the excipients listed in section 6.1 (see section 4.4).
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Hypersensitivity reactions, including anaphylaxis, dyspnoea, rash, pruritus, urticaria, and facial oedema, have been reported with use of AQUIPTA (see section 4.8). Some hypersensitivity reactions can occur days after administration. If a hypersensitivity reaction occurs, discontinue AQUIPTA and institute appropriate therapy (see section 4.3).</p><p>&nbsp;</p><p>Excipients</p><p>AQUIPTA 10 mg tablets contain less than 1 mmol sodium (23 mg) per dose, that is to say essentially &lsquo;sodium-free&rsquo;.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>CYP3A4 Inhibitors </u></p><p>Co-administration of AQUIPTA with itraconazole, a strong CYP3A4 inhibitor, resulted in a significant increase in exposure of atogepant in healthy subjects. The recommended dosage of AQUIPTA with concomitant use of strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole, voriconazole, clarithromycin, telithromycin, indinavir, nelfinavir, ritonavir, saquinavir) is 10 mg once daily. No dosage adjustment of AQUIPTA is needed with concomitant use of moderate or weak CYP3A4 inhibitors.</p><p>&nbsp;</p><p><u>OATP Inhibitors </u></p><p>Co-administration of AQUIPTA with single dose rifampicin , an OATP inhibitor, resulted in a significant increase in exposure of atogepant in healthy subjects. The recommended dosage of AQUIPTA with concomitant use of strong OATP inhibitors (e.g., rifampicin, atazanavir, ritonavir, tipranavir, ciclosporin, telmisartan) is 10 mg once daily.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Pregnancy </u>&nbsp;</p><p>&nbsp;</p><p>2</p><p>&nbsp;</p><p>There are limited data from the use of atogepant in pregnant women. Studies in animals have shown reproductive toxicity (see section 5.3). AQUIPTA is not recommended during pregnancy.</p><p><u>Breast-feeding </u>&nbsp;</p><p>It is unknown whether atogepant is excreted in human milk. Available toxicological data in animals have shown excretion of atogepant in milk (for details see 5.3). A risk to the newborns/infants cannot be excluded. A decision must be made whether to discontinue breast-feeding or to discontinue/abstain from AQUIPTA therapy taking into account the benefit of breast feeding for the child and the benefit of therapy for the woman.</p><p>&nbsp;</p><p><u>Fertility </u>&nbsp;</p><p>No human data on the effect of atogepant on fertility are available. Animal studies showed no impact on female and male fertility with atogepant treatment (see section 5.3).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>AQUIPTA has no or negligible influence on the ability to drive and use machines.</p><p>However, it may cause somnolence in some patients. Patients should exercise caution before driving or using machinery until they are reasonably certain that atogepant does not adversely affect performance.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Summary of the safety profile </u></p><p>The safety of AQUIPTA was evaluated in 2 657 patients with migraine who received at least one dose of AQUIPTA. Of these, 1 225 patients were exposed to AQUIPTA for at least 6 months and 826 patients were exposed for 12 months.</p><p>In 12-week, placebo-controlled clinical studies, 314 patients received at least one dose of AQUIPTA 10 mg once daily, 411 patients received at least one dose of AQUIPTA 30 mg once daily, 343 patients received at least one dose of AQUIPTA 30 mg twice daily, 678 patients received at least one dose of AQUIPTA 60 mg once daily, 91 patients received at least one dose of AQUIPTA 60 mg twice daily, and 663 patients received placebo.</p><p>The most commonly reported adverse drug reactions were nausea (7%), constipation (7%), and fatigue/somnolence (5%). The majority of the cases were mild, and none were serious. The adverse reaction that most commonly led to discontinuation was nausea (0.6%).</p><p><u>Tabulated list of adverse reactions </u></p><p>Table 2 lists adverse reactions for which a causal relationship between AQUIPTA and the adverse event is at least a reasonable possibility.</p><p>The adverse reactions are listed below by system organ class and frequency. Frequencies are defined as follows: very common (&ge;1/10), common (&ge;1/100 to &lt;1/10), uncommon (&ge;1/1 000 to &lt;1/100), rare (&ge;1/10 000 to &lt;1/1 000) or very rare (&lt;1/10 000).</p><p><strong>Table 2: Adverse drug reactions identified with AQUIPTA</strong></p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>System Organ Class</strong></p></td><td style="vertical-align:top"><p><strong>Frequency</strong></p></td><td style="vertical-align:top"><p><strong>Adverse Reaction</strong></p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p>Immune system disorders</p></td><td style="vertical-align:top"><p>Common<s> </s></p></td><td style="vertical-align:top"><p>Hypersensitivity (e.g.,dyspnoea rash, pruritus, urticaria, facial oedema)</p></td></tr><tr><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top"><p>Anaphylaxis</p></td></tr><tr><td style="vertical-align:top"><p>Metabolism and nutrition disorders</p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Decreased appetite</p></td></tr></tbody></table><p>&nbsp;</p><p>&nbsp;</p><p>3</p><p>&nbsp;</p><p>&nbsp;</p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>System Organ Class</strong></p></td><td style="vertical-align:top"><p><strong>Frequency</strong></p></td><td style="vertical-align:top"><p><strong>Adverse Reaction</strong></p></td></tr><tr><td style="vertical-align:top"><p>Gastrointestinal disorders</p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Nausea, constipation</p></td></tr><tr><td style="vertical-align:top"><p>General disorders and administration site conditions</p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Fatigue/somnolence</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p>Investigations</p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Weight decreased</p></td></tr><tr><td style="vertical-align:top"><p>Uncommon</p><p>&nbsp;</p></td><td style="vertical-align:top"><p>ALT/AST increased</p></td></tr></tbody></table><p>&nbsp;</p><p><u>&nbsp;</u></p><p><u>Description of selected adverse reactions&nbsp; </u><br /><em>Liver enzyme elevations</em></p><p>In placebo-controlled studies, the rate of transaminase elevations over 3 times the upper limit of normal was similar between patients treated with AQUIPTA (0.9%) and those treated with placebo (1.2%). There were cases with transaminase elevations over 3 times the upper limit of normal that were temporally associated with AQUIPTA treatment; these were asymptomatic and resolved within 8 weeks of discontinuation. There were no cases of severe liver injury or jaundice in placebo-controlled studies.</p><p><em>Changes in body weight</em></p><p>In placebo-controlled studies, the proportion of patients with a weight decrease of at least 7% at any point was 2.5% for placebo, 3.8% for AQUIPTA 10 mg once daily, 3.2% for AQUIPTA 30 mg once daily, 5.3% for AQUIPTA 30 mg twice daily, 5.3% for AQUIPTA 60 mg once daily, and 6.8% for AQUIPTA 60 mg twice daily.</p><p>&nbsp;</p><p><u>To report any side effects(s)</u></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Saudi Arabia:</p><p>The National Pharmacovigilance Centre (NPC)</p><p>- SFDA Call Center: 19999</p><p>- E-mail: npc.drug@sfda.gov.sa&nbsp; &nbsp;</p><p>-Website: https://ade.sfda.gov.sa/</p><p>&nbsp;</p><p>&nbsp; Other GCC States:</p><table border="1" cellspacing="0" cellpadding="0" style="width:588px"><tbody><tr><td style="vertical-align:top"><p>-&nbsp; Please contact the relevant competent authority.</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>There is no known antidote for AQUIPTA. Treatment of an overdose of AQUIPTA should consist of general supportive measures including monitoring of vital signs and observation of the clinical status of the patient.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: {Analgesics, antimigraine preparations}, ATC code: N02CD07</p><p><u>Mechanism of action </u></p><p>Atogepant is an orally administered, small molecule, selective calcitonin gene-related peptide (CGRP) receptor antagonist that blocks the binding of the CGRP to the receptor and antagonizes CGRP receptor function. CGRP is a neuropeptide that has been associated with migraine pathophysiology. In the trigeminovascular system, CGRP modulates nociceptive signaling and inflammation, and also functions as a vasodilator.</p><p>4</p><p>&nbsp;</p><p><u>Pharmacodynamic effects</u></p><p>At a dose 5 times the maximum recommended daily dose, AQUIPTA does not prolong the QT interval.</p><p><u>Clinical efficacy and safety </u></p><p>AQUIPTA was evaluated for the prophylaxis of migraine in two pivotal studies across the migraine spectrum in chronic and episodic migraine. The episodic migraine study (ADVANCE) enrolled patients who met International Classification of Headache Disorders (ICHD) criteria for a diagnosis of migraine with or without aura. The chronic migraine study (PROGRESS) enrolled patients who also met ICHD criteria for chronic migraine. Both studies excluded patients with myocardial infarction, stroke, or transient ischemic attacks within six months prior to screening.</p><p><em>Episodic Migraine</em></p><p>AQUIPTA was evaluated for the prophylaxis of episodic migraine (4 to 14 migraine days per month) in a randomised, multicentre, double-blind, placebo-controlled study (ADVANCE). A total of 458 patients were randomised 1:1 to receive AQUIPTA 60 mg (N = 235) or placebo (N = 223) once daily for 12 weeks. Patients were allowed to use acute headache treatments (i.e., triptans, ergotamine derivatives, NSAIDs, acetaminophen and opioids) as needed.</p><p>A total of 88% patients completed the 12-week double-blind study period. Patients had a mean age of 42 years (range: 18 to 73 years), 89% were female, and 83% were white. The mean migraine frequency at baseline was approximately 8 migraine days per month and was similar across treatment groups.</p><p>The primary efficacy endpoint was the change from baseline in mean monthly migraine days (MMD) across the 12-week treatment period. Additional endpoints included the change from baseline in mean monthly headache days, the change from baseline in mean monthly acute medication use days, the proportion of patients achieving at least a 50% and 75% reduction from baseline in mean MMD (3-month average), and change from baseline at week 12 for Headache Impact Test (HIT-6) total score and Migraine Specific Quality of Life Questionnaire version 2.1 (MSQ v2.1) Role Function-Restrictive (RFR) domain score.</p><p>The HIT-6 measures the impact of headache on participants&rsquo; ability to function at work, school, home, and in social situations. A reduction in scores from baseline indicates improvement. The MSQ v2.1 RFR domain score assesses how often migraine impacts function related to daily social and work-related activities. An increase in scores from baseline indicates improvement.</p><p>AQUIPTA treatment demonstrated statistically significant improvements for key efficacy endpoints compared to placebo in ADVANCE, as summarized in Table 3.</p><p><strong>Table 3: Efficacy endpoints in ADVANCE</strong></p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p><strong>AQUIPTA<br />60 mg</strong></p><p><strong>N=226</strong></p></td><td style="vertical-align:top"><p><strong>Placebo</strong></p><p><strong>N=216</strong></p></td></tr><tr><td colspan="3" style="vertical-align:top"><p><strong>Monthly Migraine Days (MMD) across 12 weeks</strong></p></td></tr><tr><td style="vertical-align:top"><p>Baseline</p></td><td style="vertical-align:top"><p>7.8</p></td><td style="vertical-align:top"><p>7.5</p></td></tr><tr><td style="vertical-align:top"><p>Mean change from baseline</p></td><td style="vertical-align:top"><p>-4.1</p></td><td style="vertical-align:top"><p>-2.5</p></td></tr><tr><td style="vertical-align:top"><p>Difference from placebo (95%CI)</p></td><td style="vertical-align:top"><p>-1.7 (-2.2, -1.1)</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr></tbody></table><p>&nbsp;</p><p>5</p><p>&nbsp;</p><p>&nbsp;</p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p><strong>AQUIPTA<br />60 mg</strong></p><p><strong>N=226</strong></p></td><td style="vertical-align:top"><p><strong>Placebo</strong></p><p><strong>N=216</strong></p></td></tr><tr><td style="vertical-align:top"><p><em>p</em>-value</p></td><td style="vertical-align:top"><p>&lt;0.001</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td colspan="3" style="vertical-align:top"><p><strong>Monthly Headache Days across 12 weeks</strong></p></td></tr><tr><td style="vertical-align:top"><p>Baseline</p></td><td style="vertical-align:top"><p>9.0</p></td><td style="vertical-align:top"><p>8.5</p></td></tr><tr><td style="vertical-align:top"><p>Mean change from baseline</p></td><td style="vertical-align:top"><p>-4.2</p></td><td style="vertical-align:top"><p>-2.5</p></td></tr><tr><td style="vertical-align:top"><p>Difference from placebo (95%CI)</p></td><td style="vertical-align:top"><p>-1.7 (-2.3, -1.0)</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><em>p</em>-value</p></td><td style="vertical-align:top"><p>&lt;0.001</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td colspan="3" style="vertical-align:top"><p><strong>Monthly Acute Medication Use Days across 12 weeks</strong></p></td></tr><tr><td style="vertical-align:top"><p>Baseline</p></td><td style="vertical-align:top"><p>6.9</p></td><td style="vertical-align:top"><p>6.5</p></td></tr><tr><td style="vertical-align:top"><p>Mean change from baseline</p></td><td style="vertical-align:top"><p>-3.8</p></td><td style="vertical-align:top"><p>-2.3</p></td></tr><tr><td style="vertical-align:top"><p>Difference from placebo (95%CI)</p></td><td style="vertical-align:top"><p>-1.4 (-1.9, -0.9)</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><em>p</em>-value</p></td><td style="vertical-align:top"><p>&lt;0.001</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td colspan="3" style="vertical-align:top"><p><strong>&ge; 50% MMD Responders across 12 weeks</strong></p></td></tr><tr><td style="vertical-align:top"><p>% Responders</p></td><td style="vertical-align:top"><p>59</p></td><td style="vertical-align:top"><p>29</p></td></tr><tr><td style="vertical-align:top"><p>Difference from placebo (%)</p></td><td style="vertical-align:top"><p>30</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><em>p</em>-value</p></td><td style="vertical-align:top"><p>&lt;0.001</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td colspan="3" style="vertical-align:top"><p><strong>&ge; 75% MMD Responders across 12 weeks</strong></p></td></tr><tr><td style="vertical-align:top"><p>% Responders</p></td><td style="vertical-align:top"><p>38</p></td><td style="vertical-align:top"><p>11</p></td></tr><tr><td style="vertical-align:top"><p>Difference from placebo (%)</p></td><td style="vertical-align:top"><p>27</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><em>p</em>-value</p></td><td style="vertical-align:top"><p>&lt;0.001<sup>a</sup></p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td colspan="3" style="vertical-align:top"><p><strong>HIT-6</strong><sup>b</sup><strong> at week 12</strong></p></td></tr><tr><td style="vertical-align:top"><p>Baseline</p></td><td style="vertical-align:top"><p>63.8</p></td><td style="vertical-align:top"><p>64.6</p></td></tr><tr><td style="vertical-align:top"><p>Mean change from baseline</p></td><td style="vertical-align:top"><p>-9.1</p></td><td style="vertical-align:top"><p>-5.2</p></td></tr><tr><td style="vertical-align:top"><p>Difference from placebo (95%CI)</p></td><td style="vertical-align:top"><p>-3.9 (-5.4, -2.5)</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><em>p</em>-value</p></td><td style="vertical-align:top"><p>&lt;0.001<sup>a</sup></p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td colspan="3" style="vertical-align:top"><p><strong>MSQ v2.1 RFR<sup>c</sup> at week 12</strong></p></td></tr><tr><td style="vertical-align:top"><p>Baseline</p></td><td style="vertical-align:top"><p>46.6</p></td><td style="vertical-align:top"><p>46.6</p></td></tr><tr><td style="vertical-align:top"><p>Mean change from baseline</p></td><td style="vertical-align:top"><p>31.0</p></td><td style="vertical-align:top"><p>20.0</p></td></tr><tr><td style="vertical-align:top"><p>Difference from placebo (95%CI)</p></td><td style="vertical-align:top"><p>11.0 (6.6, 15.3)</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><em>p</em>-value</p></td><td style="vertical-align:top"><p>&lt;0.001</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr></tbody></table><p><sup>a</sup> Not adjusted for multiple comparisons</p><p><sup>b</sup> Headache Impact Test total score</p><p><sup>c</sup> Migraine Specific Quality of Life Questionnaire version 2.1 Role Function-Restrictive domain score</p><p>&nbsp;</p><p>6</p><p>&nbsp;</p><p>Additional pre-specified endpoints included the Activity Impairment in Migraine-Diary (AIM-D) domains and the MSQ v2.1 Role Function-Preventive (RFP) and Emotional Function (EF) domains. The AIM-D evaluates difficulty with performance of daily activities (PDA domain) and physical impairment (PI domain) due to migraine. A reduction in scores from baseline indicates improvement. MSQ v2.1 assesses how migraine prevents daily social and work-related activities (RFP domain) and the emotions associated with migraine (EF domain). An increase in scores from baseline indicates improvement.</p><p>The mean change from baseline for the AIM-D PDA domain (placebo: -6.1,</p><p>60 mg: -9.1) and AIM-D PI domain (placebo: -4.0, 60 mg: -6.4) demonstrated greater improvements with AQUIPTA 60 mg QD across the 12-week treatment period. The change was significant when adjusted for multiple comparisons. At week 12, the mean change from baseline for the MSQ v2.1 RFP domain (placebo: 16.9,</p><p>60 mg: 23.9) and EF domain (placebo: 18.2, 60 mg: 28.8) demonstrated greater improvements with AQUIPTA 60 mg QD (not controlled for multiple comparisons).</p><p>Figure 1 shows the mean change from baseline in MMD in ADVANCE. Patients treated with AQUIPTA 60 mg QD had greater mean decreases from baseline in MMD across the 12-week treatment period compared to patients who received placebo. During the first month of treatment (starting the first day after the initial dose), AQUIPTA 60 mg QD had greater mean decreases from baseline in weekly migraine days compared to placebo-treated patients.</p><p><strong>Figure 1: Change from baseline in monthly migraine days in ADVANCE</strong></p><p>&nbsp;</p><p><img src="data:image/png;base64,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" alt="" width="832" height="687" vspace="0" hspace="0" border="0" style="width:832px;height:687px;margin-top:0px;margin-bottom:0px;margin-left:0px;margin-right:0px;border:0px solid black;" /></p><p>&nbsp;</p><p>In patients failing one or more prophylactic medications, the treatment difference for the reduction of MMD observed as compared to placebo across the 12-week treatment period was -2.2 (95% CI: -3.0, -1.3) for AQUIPTA 60 mg.</p><p>The proportions of participants with &ge; 50%, &ge;75%, and 100% reduction in monthly migraine days was greater in the AQUIPTA 60 mg QD treatment group than in the placebo treatment group for each of the 4-week intervals assessed (weeks 1 to 4, 5 to 8, and 9 to 12), and the percentage of responders at each threshold increased over time.</p><p><strong>Table 4: Reduction of &ge; 50%, &ge; 75%, and 100% from baseline in MMD by 4-week interval<sup>a</sup></strong><strong> </strong></p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p><strong>AQUIPTA<br />60 mg</strong></p><p><strong>(%)</strong></p></td><td style="vertical-align:top"><p><strong>Placebo</strong></p><p><strong>(%)</strong></p></td></tr><tr><td colspan="3" style="vertical-align:top"><p><strong>&ge; 50% MMD Responders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Weeks 1-4</p></td><td style="vertical-align:top"><p>59</p></td><td style="vertical-align:top"><p>27</p></td></tr><tr><td style="vertical-align:top"><p>Weeks 5-8</p></td><td style="vertical-align:top"><p>66</p></td><td style="vertical-align:top"><p>46</p></td></tr><tr><td style="vertical-align:top"><p>Weeks 9-12</p></td><td style="vertical-align:top"><p>71</p></td><td style="vertical-align:top"><p>44</p></td></tr><tr><td colspan="3" style="vertical-align:top"><p><strong>&ge; 75% MMD Responders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Weeks 1-4</p></td><td style="vertical-align:top"><p>39</p></td><td style="vertical-align:top"><p>10</p></td></tr><tr><td style="vertical-align:top"><p>Weeks 5-8</p></td><td style="vertical-align:top"><p>40</p></td><td style="vertical-align:top"><p>17</p></td></tr><tr><td style="vertical-align:top"><p>Weeks 9-12</p></td><td style="vertical-align:top"><p>49</p></td><td style="vertical-align:top"><p>22</p></td></tr><tr><td colspan="3" style="vertical-align:top"><p><strong>100% MMD Responders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Weeks 1-4</p></td><td style="vertical-align:top"><p>19</p></td><td style="vertical-align:top"><p>4</p></td></tr><tr><td style="vertical-align:top"><p>Weeks 5-8</p></td><td style="vertical-align:top"><p>24</p></td><td style="vertical-align:top"><p>8</p></td></tr><tr><td style="vertical-align:top"><p>Weeks 9-12</p></td><td style="vertical-align:top"><p>27</p></td><td style="vertical-align:top"><p>12</p></td></tr></tbody></table><p><sup>a</sup> p &lt; 0.001 for all comparisons between AQUIPTA 60 mg and placebo (not adjusted for multiple comparisons)</p><p><em>Long-term efficacy</em></p><p>Efficacy was sustained for up to one year in an open-label study in which patients with episodic migraine received AQUIPTA 60 mg once daily. 68.4% of patients completed the treatment period. The reduction in the least-squares mean number of monthly migraine days in the first month (weeks 1-4) was -3.8 days and improved to a least-squares mean reduction of -5.2 days in the last month (weeks 49-52). Approximately 84%, 70%, and 48% of patients reported &ge;50%, &ge;75%, and 100% reduction in monthly migraine days at weeks 49-52, respectively.</p><p><em>Chronic Migraine</em></p><p>AQUIPTA was evaluated for the prophylaxis of chronic migraine (15 or more headache days per month with at least 8 migraine days) in a randomised, multicentre, double-blind, placebo-controlled study (PROGRESS). A total of 521 patients were randomised 1:1 to receive AQUIPTA 60 mg (N = 262) or placebo (N = 259) once daily for 12 weeks. A subset of patients (11%) was allowed to use one concomitant</p><p>&nbsp;</p><p>8</p><p>&nbsp;</p><p>migraine prophylaxis medication (e.g., amitriptyline, propranolol, topiramate). Patients were allowed to use acute headache treatments (i.e., triptans, ergotamine derivatives, NSAIDs, acetaminophen and opioids) as needed. Patients with acute medication overuse and medication overuse headache also were enrolled.</p><p>A total of 463 (89%) patients completed the 12-week double-blind study. Patients had a mean age of 42 years (range: 18 to 74 years), 87% were female, and 59% were white. The mean migraine frequency at baseline was approximately 19 migraine days per month and was similar across treatment groups.</p><p>The primary efficacy endpoint was the change from baseline in mean MMD across the 12-week treatment period. Additional endpoints included the change from baseline in mean monthly headache days, the change from baseline in mean monthly acute medication use days, the proportion of patients achieving at least a 50% and 75% reduction from baseline in mean MMD (3-month average), and change from baseline at week 12 for HIT-6 total score and MSQ v2.1 RFR domain score.</p><p>Key efficacy results of PROGRESS are summarized in Table 5.</p><p><strong>Table 5: Efficacy endpoints in PROGRESS</strong></p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p><strong>AQUIPTA<br />60 mg</strong></p><p><strong>N=257</strong></p></td><td style="vertical-align:top"><p><strong>Placebo</strong></p><p><strong>N=249</strong></p></td></tr><tr><td colspan="3" style="vertical-align:top"><p><strong>Monthly Migraine Days (MMD) across 12 weeks</strong></p></td></tr><tr><td style="vertical-align:top"><p>Baseline</p></td><td style="vertical-align:top"><p>19.2</p></td><td style="vertical-align:top"><p>19.0</p></td></tr><tr><td style="vertical-align:top"><p>Mean change from baseline</p></td><td style="vertical-align:top"><p>-6.8</p></td><td style="vertical-align:top"><p>-5.1</p></td></tr><tr><td style="vertical-align:top"><p>Difference from placebo (95% CI)</p></td><td style="vertical-align:top"><p>-1.7 (-2.7, -0.6)</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><em>p</em>-value</p></td><td style="vertical-align:top"><p>0.002</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td colspan="3" style="vertical-align:top"><p><strong>Monthly Headache Days across 12 weeks</strong></p></td></tr><tr><td style="vertical-align:top"><p>Baseline</p></td><td style="vertical-align:top"><p>21.5</p></td><td style="vertical-align:top"><p>21.4</p></td></tr><tr><td style="vertical-align:top"><p>Mean change from baseline</p></td><td style="vertical-align:top"><p>-6.9</p></td><td style="vertical-align:top"><p>-5.2</p></td></tr><tr><td style="vertical-align:top"><p>Difference from placebo (95% CI)</p></td><td style="vertical-align:top"><p>-1.7 (-2.8, -0.7)</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><em>p</em>-value</p></td><td style="vertical-align:top"><p>0.002</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td colspan="3" style="vertical-align:top"><p><strong>Monthly Acute Medication Use Days across 12 weeks</strong></p></td></tr><tr><td style="vertical-align:top"><p>Baseline</p></td><td style="vertical-align:top"><p>15.5</p></td><td style="vertical-align:top"><p>15.3</p></td></tr><tr><td style="vertical-align:top"><p>Mean change from baseline</p></td><td style="vertical-align:top"><p>-6.2</p></td><td style="vertical-align:top"><p>-4.1</p></td></tr><tr><td style="vertical-align:top"><p>Difference from placebo (95% CI)</p></td><td style="vertical-align:top"><p>-2.1 (-3.1, -1.1)</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><em>p</em>-value</p></td><td style="vertical-align:top"><p>0.002</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td colspan="3" style="vertical-align:top"><p><strong>&ge; 50% MMD Responders across 12 weeks</strong></p></td></tr><tr><td style="vertical-align:top"><p>% Responders</p></td><td style="vertical-align:top"><p>40</p></td><td style="vertical-align:top"><p>27</p></td></tr><tr><td style="vertical-align:top"><p>Difference from placebo (%)</p></td><td style="vertical-align:top"><p>14</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><em>p</em>-value</p></td><td style="vertical-align:top"><p>0.002</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td colspan="3" style="vertical-align:top"><p><strong>&ge; 75% MMD Responders across 12 weeks</strong></p></td></tr></tbody></table><p>&nbsp;</p><p>&nbsp;</p><p>9</p><p>&nbsp;</p><p>&nbsp;</p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p><strong>AQUIPTA<br />60 mg</strong></p><p><strong>N=257</strong></p></td><td style="vertical-align:top"><p><strong>Placebo</strong></p><p><strong>N=249</strong></p></td></tr><tr><td style="vertical-align:top"><p>% Responders</p></td><td style="vertical-align:top"><p>18</p></td><td style="vertical-align:top"><p>6</p></td></tr><tr><td style="vertical-align:top"><p>Difference from placebo (%)</p></td><td style="vertical-align:top"><p>13</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><em>p</em>-value</p></td><td style="vertical-align:top"><p>&lt;0.001<sup>a</sup></p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td colspan="3" style="vertical-align:top"><p><strong>HIT-6</strong><sup>b</sup><strong> at week 12</strong></p></td></tr><tr><td style="vertical-align:top"><p>Baseline</p></td><td style="vertical-align:top"><p>64.4</p></td><td style="vertical-align:top"><p>63.8</p></td></tr><tr><td style="vertical-align:top"><p>Mean change from baseline</p></td><td style="vertical-align:top"><p>-7.8</p></td><td style="vertical-align:top"><p>-5.2</p></td></tr><tr><td style="vertical-align:top"><p>Difference from placebo (95% CI)</p></td><td style="vertical-align:top"><p>-2.7 (-4.0, -1.3)</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><em>p</em>-value</p></td><td style="vertical-align:top"><p>&lt;0.001</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td colspan="3" style="vertical-align:top"><p><strong>MSQ v2.1 RFR</strong><sup>c</sup><strong> at week 12</strong></p></td></tr><tr><td style="vertical-align:top"><p>Baseline</p></td><td style="vertical-align:top"><p>43.3</p></td><td style="vertical-align:top"><p>44.1</p></td></tr><tr><td style="vertical-align:top"><p>Mean change from baseline</p></td><td style="vertical-align:top"><p>23.1</p></td><td style="vertical-align:top"><p>17.3</p></td></tr><tr><td style="vertical-align:top"><p>Difference from placebo (95% CI)</p></td><td style="vertical-align:top"><p>5.8 (2.2, 9.4)</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><em>p</em>-value</p></td><td style="vertical-align:top"><p>0.002</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr></tbody></table><p><sup>a</sup> Not adjusted for multiple comparisons</p><p><sup>b</sup> Headache Impact Test total score</p><p><sup>c</sup> Migraine Specific Quality of Life Questionnaire version 2.1 Role Function-Restrictive domain score</p><p>Additional pre-specified endpoints included the MSQ v2.1 RFP and EF domains. The mean change from baseline for the MSQ v2.1 RFP domain (placebo: 13.6, 60 mg: 19.9) and EF domain (placebo: 15.7, 60 mg: 22.4) demonstrated greater improvements with AQUIPTA 60 mg QD at week 12 (not controlled for multiple comparisons).</p><p>Figure 2 shows the mean change from baseline in MMD in PROGRESS. Patients treated with AQUIPTA 60 mg QD had a greater mean decrease from baseline in MMD across the 12-week treatment period compared to patients who received placebo.</p><p>&nbsp;</p><p><img src="data:image/png;base64,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" alt="" width="811" height="734" vspace="0" hspace="0" border="0" style="width:811px;height:734px;margin-top:0px;margin-bottom:0px;margin-left:0px;margin-right:0px;border:0px solid black;" /></p><p>&nbsp;</p><p>In patients failing one or more prophylactic medications with the same mechanism of action, the treatment difference for the reduction of MMD observed between AQUIPTA 60 mg and placebo across the 12-week treatment period was -1.5 (95% CI: -3.3, 0.4). In patients failing two or more prophylactic medications with different mechanisms of action, the treatment difference was -2.4 (95% CI: -4.2, &nbsp;&nbsp;&nbsp;&nbsp;-0.6).</p><p>The proportions of participants with &ge;50%, &ge;75%, and 100% reduction in monthly migraine days was greater in the AQUIPTA 60 mg QD treatment group than in the placebo treatment group for each of the 4-week intervals assessed (weeks 1 to 4, 5 to 8, and 9 to 12), and the percentage of responders at each threshold increased over time.</p><p><strong>Table 6: Reduction of &ge;50%, &ge;75%, and 100% from baseline in MMD by 4-week interval</strong></p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p><strong>AQUIPTA<br />60 mg</strong></p><p><strong>(%)</strong></p></td><td style="vertical-align:top"><p><strong>Placebo</strong></p><p><strong>(%)</strong></p></td></tr><tr><td colspan="3" style="vertical-align:top"><p><strong>&ge; 50% MMD Responders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Weeks 1-4</p></td><td style="vertical-align:top"><p>39<sup>a</sup></p></td><td style="vertical-align:top"><p>18</p></td></tr><tr><td style="vertical-align:top"><p>Weeks 5-8</p></td><td style="vertical-align:top"><p>43<sup>a</sup></p></td><td style="vertical-align:top"><p>31</p></td></tr><tr><td style="vertical-align:top"><p>Weeks 9-12</p></td><td style="vertical-align:top"><p>44</p></td><td style="vertical-align:top"><p>38</p></td></tr></tbody></table><p>&nbsp;</p><p>11</p><p>&nbsp;</p><p>&nbsp;</p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p><strong>AQUIPTA<br />60 mg</strong></p><p><strong>(%)</strong></p></td><td style="vertical-align:top"><p><strong>Placebo</strong></p><p><strong>(%)</strong></p></td></tr><tr><td colspan="3" style="vertical-align:top"><p><strong>&ge; 75% MMD Responders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Weeks 1-4</p></td><td style="vertical-align:top"><p>17<sup>a</sup></p></td><td style="vertical-align:top"><p>5</p></td></tr><tr><td style="vertical-align:top"><p>Weeks 5-8</p></td><td style="vertical-align:top"><p>24<sup>a</sup></p></td><td style="vertical-align:top"><p>10</p></td></tr><tr><td style="vertical-align:top"><p>Weeks 9-12</p></td><td style="vertical-align:top"><p>28<sup>a</sup></p></td><td style="vertical-align:top"><p>15</p></td></tr><tr><td colspan="3" style="vertical-align:top"><p><strong>100% MMD Responders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Weeks 1-4</p></td><td style="vertical-align:top"><p>4<sup>b</sup></p></td><td style="vertical-align:top"><p>0</p></td></tr><tr><td style="vertical-align:top"><p>Weeks 5-8</p></td><td style="vertical-align:top"><p>6<sup>a</sup></p></td><td style="vertical-align:top"><p>&lt;1</p></td></tr><tr><td style="vertical-align:top"><p>Weeks 9-12</p></td><td style="vertical-align:top"><p>7<sup>b</sup></p></td><td style="vertical-align:top"><p>3</p></td></tr></tbody></table><p><sup>a</sup> p&lt;0.01 for comparison between AQUIPTA 60 mg and placebo<br />(not adjusted for multiple comparisons)</p><p><sup>b</sup> p&lt;0.03 for comparison between AQUIPTA 60 mg and placebo<br />(not adjusted for multiple comparisons)</p><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Absorption </u>&nbsp;</p><p>Following oral administration of AQUIPTA, atogepant is rapidly absorbed with plasma concentrations &gt;14 nM (EC90 based on capsaicin induced dermal vasodilation model [CIDV]) within 0.5 hours and median Tmax values ranging from 1 to 2 hours. Atogepant displays dose-proportional pharmacokinetics through 300 mg single dose with no accumulation upon once daily dosing.</p><p><em>Effect of food</em></p><p>When AQUIPTA was administered with a high-fat meal, the food effect was not significant (AUC and Cmax were reduced by approximately 18% and 22%, respectively, with no effect on median time to maximum atogepant plasma concentration). AQUIPTA was administered without regard to food in clinical efficacy studies.</p><p><u>Distribution </u>&nbsp;</p><p>Plasma protein binding of atogepant was not concentration-dependent in the range of 0.1 to 10 &micro;M; the unbound fraction of atogepant was approximately 4.7% in human plasma. The mean apparent volume of distribution of atogepant (V<sub>z</sub>/F) after oral administration is approximately 292 L.</p><p><u>Biotransformation </u>&nbsp;</p><p>Atogepant is eliminated mainly through metabolism, primarily by CYP3A4. The parent compound (atogepant), and a glucuronide conjugate metabolite (M23) were the most prevalent circulating components in human plasma.</p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><em>In vitro studies<br />Enzymes</em></p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td><p>In vitro, atogepant is not an inhibitor for CYPs 3A4, 1A2,</p></td><td><p>2B6,</p></td><td><p>2C8,</p></td><td><p>2C9, 2C19, or</p></td></tr></tbody></table><p>2D6 at clinically relevant concentrations. Atogepant does not inhibit MAO-A or<br />UGT1A1 at clinically relevant concentrations. Atogepant is not anticipated to be a</p><p>&nbsp;</p><p>12</p><p>&nbsp;</p><p>clinically significant perpetrator of drug-drug interactions through CYP450s, MAO-A, or UGT1A1 inhibition.</p><p>Atogepant is not an inducer of CYP1A2, CYP2B6, or CYP3A4 at clinically relevant concentrations.</p><p><em><u>Transporters </u></em><em>&nbsp;</em></p><p>Atogepant is a substrate of P-gp, BCRP, OATP1B1, OATP1B3, and OAT1. Dose adjustment for concomitant use of AQUIPTA with strong inhibitors of OATP is recommended based on a clinical interaction study with a strong OATP inhibitor.</p><p>Co-administration of atogepant with BCRP and/or P-gp inhibitors is not expected to increase the exposure of atogepant. Atogepant is not a substrate of OAT3, OCT2, or MATE1.</p><p>Atogepant is not an inhibitor of P-gp, BCRP, OAT1, OAT3, NTCP, BSEP, MRP3, or MRP4 at clinically relevant concentrations. Atogepant is a weak inhibitor of OATP1B1, OATP1B3, OCT1, and MATE1. No clinical drug interactions are expected for atogepant as a perpetrator with these transporters.</p><p><em>In vivo studies<br /><u>CYP3A4 inhibitors </u></em></p><p>Co-administration of AQUIPTA with itraconazole, a strong CYP3A4 inhibitor, resulted in a clinically significant increase (Cmax by 2.15-fold and AUC by 5.5-fold) in the exposure of atogepant in healthy subjects.</p><p>Physiologically based pharmacokinetic (PBPK) modeling suggested co-administration of AQUIPTA with moderate (e.g., ciclosporin, ciprofloxacin, fluconazole, fluvoxamine, grapefruit juice) or weak (e.g., cimetidine, esomeprazole) CYP3A4 inhibitors increases atogepant AUC by 1.7- and 1.1-fold, respectively. The changes in atogepant exposure when coadministered with weak or moderate CYP3A4 inhibitors are not expected to be clinically significant.</p><p><em><u>CYP3A4 inducers </u></em></p><p>Co-administration of AQUIPTA with rifampicin, a strong CYP3A4 inducer, decreased atogepant AUC by 60% and Cmax by 30% in healthy subjects. No dedicated drug interaction studies were conducted to assess concomitant use with moderate CYP3A4 inducers. Moderate inducers of CYP3A4 can decrease atogepant exposure. Clinically significant interaction was not observed with concomitant administration of AQUIPTA and topiramate, a weak inducer of CYP3A4.</p><p><em><u>BCRP/OATP/P-gp inhibitors </u></em></p><p>Co-administration of AQUIPTA with single dose rifampicin, a strong OATP inhibitor, increased atogepant AUC by 2.85-fold and Cmax by 2.23-fold in healthy subjects.</p><p>Co-administration of AQUIPTA with quinidine, a P-gp inhibitor, increased atogepant AUC by 26% and Cmax by 4% in healthy subjects. The changes in atogepant exposure when co-administered with P-gp inhibitors are not expected to be clinically significant.</p><p>PBPK modeling suggests that co-administration of AQUIPTA with BCRP inhibitors increases atogepant exposure by 1.2-fold. This increase is not expected to be clinically significant.</p><p>&nbsp;</p><p><em><u>OCT1 substrates</u></em></p><p>Co-administration of sumatriptan, an OCT1 substrate, with AQUIPTA did not result in significant change in the systemic exposure of either drug.</p><p>&nbsp;</p><p><em><u>Other drug interaction evaluations </u></em></p><p>Co-administration of AQUIPTA with oral contraceptive components ethinyl estradiol and levonorgestrel, famotidine, esomeprazole, acetaminophen, naproxen,</p><p>&nbsp;</p><p>13</p><p>&nbsp;</p><p>sumatriptan, topiramate, or ubrogepant did not result in significant pharmacokinetic interactions for either atogepant or co-administered drugs.</p><p><u>Elimination </u>&nbsp;</p><p>The elimination half-life of atogepant is approximately 11 hours. The mean apparent oral clearance (CL/F) of atogepant is approximately 19 L/h. Following single oral dose of 50 mg <sup>14</sup>C-atogepant to healthy male subjects, 42% and 5% of the dose was recovered as unchanged atogepant in faeces and urine, respectively.</p><p><u>Specific populations </u></p><p><em>Patients with renal impairment</em></p><p>The renal route of elimination plays a minor role in the clearance of atogepant. Based on PBPK and population pharmacokinetic analysis, there is no significant difference in the pharmacokinetics of atogepant in patients with mild or moderate renal impairment (CLcr 30-89 mL/min) relative to those with normal renal function (CLcr &ge;90 mL/min). As patients with severe renal impairment or end-stage renal disease (ESRD; CLcr &lt;30 mL/min) have not been studied, use of atogepant (10 mg) is recommended in those patients.</p><p><em>Patients with hepatic impairment</em></p><p>In patients with pre-existing mild (Child-Pugh Class A), moderate (Child-Pugh Class B), or severe hepatic impairment (Child-Pugh Class C), total atogepant exposure was increased by 24%, 15% and 38%, respectively. However, unbound atogepant exposure was approximately 3-fold higher in patients with severe hepatic impairment. Avoid use of AQUIPTA in patients with severe hepatic impairment.</p><p><em>Other specific populations</em></p><p>Based on a population pharmacokinetic analysis, age, sex, race, and body weight did not have a significant effect on the pharmacokinetics (Cmax and AUC) of atogepant. Therefore, no dose adjustments are warranted based on these factors.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Carcinogenicity </u>&nbsp;</p><p>Atogepant was administered orally to mice (0, 5, 20, or 75 mg/kg/day in males; 0, 5, 30, or 160 mg/kg/day in females) and rats (0, 10, 20, or 100 mg/kg in males; 0, 25, 65, or 200 mg/kg in females) for up to 2 years. There was no evidence of drug-related tumours in either species. Plasma exposures at the highest doses tested in mice and rats were approximately 8 and 20-35 times, respectively, that in humans at the maximum recommended human dose (MRHD) of 60 mg/day.</p><p><u>Mutagenicity </u>&nbsp;</p><p>Atogepant was negative in in vitro (Ames, chromosomal aberration test in Chinese Hamster Ovary cells) and in vivo (rat bone marrow micronucleus) assays.</p><p><u>Impairment of fertility </u></p><p>Oral administration of atogepant (0, 5, 20, or 125 mg/kg/day) to male and female rats prior to and during mating and continuing in females to Gestation Day 7 resulted in no adverse effects on fertility or reproductive performance. Plasma exposures (AUC) at the highest dose tested are approximately 15 times that in humans at the MRHD.</p><p><u>Reproductive and developmental toxicology </u></p><p>Oral administration of atogepant to pregnant rats and rabbits during the period of organogenesis resulted in decreased fetal body weight in rats and an</p><p>increased incidence of fetal visceral and skeletal variations at doses tested</p><p>&nbsp;</p><p>14</p><p>&nbsp;</p><p>associated with minimal maternal toxicity. At the no-effect dose for adverse effects on embryofetal development, plasma exposure</p><p>(AUC) was approximately 4 times in rats and 3 times in rabbits that in humans at the MRHD of 60 mg/day.</p><p>Oral administration of atogepant</p><p>to rats throughout gestation and lactation resulted in decreased pup body weight at the highest dose tested which persisted into adulthood. At the no observed effect dose, Plasma exposure (AUC) &nbsp;wasapproximately 5times that in humans at the MRHD.</p><p>In lactating rats, oral dosing with atogepant resulted in levels of atogepant in milk approximately 2-fold higher than those in maternal plasma.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>List of excipients</strong></p><p>Polyvinylpyrrolidone/Vinyl acetate copolymer</p><p>Vitamin E polyethylene glycol succinate</p><p>Mannitol</p><p>Microcrystalline cellulose</p><p>Sodium chloride</p><p>Croscarmellose sodium</p><p>Colloidal silicon dioxide</p><p>Sodium stearyl fumarate</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                3 years
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30˚ C</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Blisters in packs containing 28 tablets.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Any unused medicinal product or waste material should be disposed of in accordance with local requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                AbbVie Ltd. 
Maidenhead 
SL6 4UB
UK

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                09/10/2024
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>